Series A - Therachon
Investment Firm
Overview
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases
Announced Date
Jan 06, 2017
Funding Type
Series A
Highlights
Location
Switzerland, Europe
Social
Investor Lead
N/A
Participant Investors
4
Round Details and Background
Therachon raised $5000000 on 2017-01-06 in Series A
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 09, 2018 |  Series B - Therachon | 8 | - | 60.0M |
| Jan 06, 2017 | Series A - Therachon | 4 | - | 5.0M |
| Sep 30, 2015 | Series A - Therachon | 4 | - | 35.0M |
Recent Activity
There is no recent news or activity for this profile.